Mary Reilly

Health Technology

Profile

Mary Reilly worked as an Associate Director & Project Leader at Elan Pharmaceuticals, LLC and as a VP-Operations & Pharmaceutical Development at Opsona Therapeutics Ltd.

Former positions of Mary Reilly

Companies	Position	End
Opsona Therapeutics Ltd. Opsona Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Opsona Therapeutics Ltd. operates as a immunology drug development company. It focuses on novel therapeutics and specializes in the prevention and treatment of solid organ transplantation, cancer, diabetes, autoimmune, inflammatory and Alzheimer’s diseases. The firm developed OPN-305, an antibody to reduce pro-inflammatory cytokine production, which is now at the clinical testing phase. The company was founded by Luke O'Neill, Kingston Mills and Dermot Kelleher in 2004 and is headquartered Dublin, Ireland.	Chief Operating Officer	-
Elan Pharmaceuticals, LLC Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA.	Corporate Officer/Principal	-

See the detail of Mary Reilly's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies